Proton Pump Inhibitors May Compromise Efficacy of Palbociclib in Patients With Breast Cancer

Concomitant use of proton pump inhibitors may lessen the therapeutic benefit of palbociclib in patients with advanced breast cancer.

Related Keywords

,Kwons H ,Jungh I ,